WHO ICTRP trial
Evaluating Sinarest Plus Suspension for Children with Common Cold: Safety and…
CTRI/2024/11/077320 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2024/11/077320 |
|---|---|
| Public title | Evaluating Sinarest Plus Suspension for Children with Common Cold: Safety and Efficacy Study |
| Scientific title | A multicentric, non-randomized, open-label, non-comparative, active post-marketing surveillance study to evaluate the safety and efficacy of Sinarest Plus Suspension in children with common cold. - NIL |
| Primary sponsor | Centaur Pharmaceuticals Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: J00- Acute nasopharyngitis [common cold] |
| Interventions | Intervention1: Sinarest Plus Suspension: Sinarest Plus Suspension, FDC of Paracetamol 250 mg, Phenylephrine Hydrochloride 5 mg, Chlorpheniramine Maleate 2 mg, Sodium citrate 60 mg and menthol 1 mg per 5 ml is indicated for children with… |
| Registration date | Nov 25, 2024 |
| Target size | 280 |
| Secondary IDs | 088-20 version 1.0, dated 20-January-2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: